Locus-specific proteome decoding reveals Fpt1 as a chromatin-associated negative regulator of RNA polymerase III assembly.

RNA polymerase III chromatin chromatin proteome nutrient signaling tDNA tRNA transcription

Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
07 Dec 2023
Historique:
received: 18 04 2023
revised: 27 09 2023
accepted: 26 10 2023
pubmed: 24 11 2023
medline: 24 11 2023
entrez: 23 11 2023
Statut: ppublish

Résumé

Transcription of tRNA genes by RNA polymerase III (RNAPIII) is tuned by signaling cascades. The emerging notion of differential tRNA gene regulation implies the existence of additional regulatory mechanisms. However, tRNA gene-specific regulators have not been described. Decoding the local chromatin proteome of a native tRNA gene in yeast revealed reprogramming of the RNAPIII transcription machinery upon nutrient perturbation. Among the dynamic proteins, we identified Fpt1, a protein of unknown function that uniquely occupied RNAPIII-regulated genes. Fpt1 binding at tRNA genes correlated with the efficiency of RNAPIII eviction upon nutrient perturbation and required the transcription factors TFIIIB and TFIIIC but not RNAPIII. In the absence of Fpt1, eviction of RNAPIII was reduced, and the shutdown of ribosome biogenesis genes was impaired upon nutrient perturbation. Our findings provide support for a chromatin-associated mechanism required for RNAPIII eviction from tRNA genes and tuning the physiological response to changing metabolic demands.

Identifiants

pubmed: 37995691
pii: S1097-2765(23)00908-5
doi: 10.1016/j.molcel.2023.10.037
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4205-4221.e9

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests B.F.P. is an owner of and has a financial interest in Peconic, which uses the ChIP-exo technology (U.S. Patent 20100323361A1) implemented in this study and could potentially benefit from the outcomes of this research.

Auteurs

Maria Elize van Breugel (ME)

Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.

Ila van Kruijsbergen (I)

Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.

Chitvan Mittal (C)

Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA; Department of Molecular Biology and Genetics, Biotechnology Building, Cornell University, Ithaca, NY 14853, USA.

Cor Lieftink (C)

Division of Molecular Carcinogenesis and Robotics and Screening Center, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.

Ineke Brouwer (I)

Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Division of Gene Regulation, Netherlands Cancer Institute, Oncode Institute, Amsterdam 1066 CX, the Netherlands.

Teun van den Brand (T)

Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.

Roelof J C Kluin (RJC)

Genomics Core Facility, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.

Liesbeth Hoekman (L)

Proteomics Facility, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.

Renée X Menezes (RX)

Biostatistics Centre and Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.

Tibor van Welsem (T)

Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.

Andrea Del Cortona (A)

VIB-KU Leuven Center for Microbiology, KU Leuven, 3001 Heverlee-Leuven, Belgium.

Muddassir Malik (M)

Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.

Roderick L Beijersbergen (RL)

Division of Molecular Carcinogenesis and Robotics and Screening Center, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.

Tineke L Lenstra (TL)

Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Division of Gene Regulation, Netherlands Cancer Institute, Oncode Institute, Amsterdam 1066 CX, the Netherlands.

Kevin J Verstrepen (KJ)

VIB-KU Leuven Center for Microbiology, KU Leuven, 3001 Heverlee-Leuven, Belgium.

B Franklin Pugh (BF)

Department of Molecular Biology and Genetics, Biotechnology Building, Cornell University, Ithaca, NY 14853, USA.

Fred van Leeuwen (F)

Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Department of Medical Biology, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, the Netherlands. Electronic address: fred.v.leeuwen@nki.nl.

Classifications MeSH